IMN || Oncology

Cancer risk elevated before and 90 days after diabetes diagnosis

Posted on: 16/06/2014 - 17:10

SAN FRANCISCO – Among diabetes patients, the risk of cancer was significantly increased before diagnosis and 3 months after diabetes diagnosis, but not beyond that time point, results from a...

Field of Interest: Oncology

Type: News Item

Insomnia with very short sleep duration is a risk factor for cancer

Posted on: 11/06/2014 - 19:00

MINNEAPOLIS – People who have the type of insomnia characterized by a sharply shortened duration of sleep are at increased risk for cancer, a longitudinal cohort study showed. In the study of more...

Field of Interest: Oncology

Type: News Item

PLCO data: Prostate Ca screening for genetic high risk improves survival

Posted on: 06/06/2014 - 21:50

ORLANDO – Screening men who are at high genetic risk for prostate cancer appears to provide a mortality benefit, according to an analysis of data from a randomized trial. Of 73,200 men who...

Field of Interest: Oncology

Type: News Item

Two behavioral therapies are on par for alleviating insomnia in cancer survivors

Posted on: 05/06/2014 - 20:45

MINNEAPOLIS – Both cognitive behavioral therapy for insomnia and mindfulness-based stress reduction training lessened insomnia in a group of cancer survivors, although the former works faster, new...

Field of Interest: Oncology

Type: News Item

Dogs detect prostate cancer VOCs in urine

Posted on: 04/06/2014 - 20:20

ORLANDO – Specially trained dogs accurately detected specific prostate cancer volatile organic compounds in urine samples from patients with varying stages of disease and risk levels in a controlled...

Field of Interest: Oncology

Type: News Item

High rate of durable responses to pembrolizumab in metastatic melanoma

Posted on: 03/06/2014 - 19:35

CHICAGO – The investigational targeted agent pembrolizumab induced durable treatment responses in a high percentage of patients with advanced metastatic melanoma, in a phase I study. Of 411...

Field of Interest: Oncology

Type: News Item

VIDEO: New option arises for young women with hormone-sensitive breast cancer

Posted on: 02/06/2014 - 22:40

CHICAGO – The aromatase inhibitor exemestane is more effective than tamoxifen in preventing breast cancer recurrence in premenopausal women also receiving ovarian function suppression as adjuvant...

Field of Interest: Oncology

Type: News Item

VIDEO: New option arises for young women with hormone-sensitive breast cancer

Posted on: 02/06/2014 - 22:40

Field of Interest: Pulmonology

Type: News Item

VIDEO: Adding docetaxel up front improved survival in prostate cancer by more than a year

Posted on: 02/06/2014 - 20:50

CHICAGO –The answer was nearly a decade in coming, but worth the wait: Adding docetaxel to initial hormonal therapy in men with metastatic, hormone-sensitive prostate cancer can extend overall...

Field of Interest: Oncology

Type: News Item

Drug combo extends survival by more than 1 year in metastatic prostate cancer patients

Posted on: 02/06/2014 - 18:55

CHICAGO – The answer was nearly a decade in coming, but worth the wait: Adding docetaxel to initial hormonal therapy in men with metastatic, hormone-sensitive prostate cancer can extend overall...

Field of Interest: Oncology

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters